FI83766C - Foerfarande foer framstaelning av terapeutiskt anvaendbara n-2,3-butadienyl-1,4-butandiaminderivat. - Google Patents

Foerfarande foer framstaelning av terapeutiskt anvaendbara n-2,3-butadienyl-1,4-butandiaminderivat. Download PDF

Info

Publication number
FI83766C
FI83766C FI844792A FI844792A FI83766C FI 83766 C FI83766 C FI 83766C FI 844792 A FI844792 A FI 844792A FI 844792 A FI844792 A FI 844792A FI 83766 C FI83766 C FI 83766C
Authority
FI
Finland
Prior art keywords
formula
butadienyl
amino
tert
protected
Prior art date
Application number
FI844792A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI844792A0 (fi
FI83766B (fi
FI844792L (fi
Inventor
Philippe Bey
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI844792A0 publication Critical patent/FI844792A0/fi
Publication of FI844792L publication Critical patent/FI844792L/fi
Application granted granted Critical
Publication of FI83766B publication Critical patent/FI83766B/fi
Publication of FI83766C publication Critical patent/FI83766C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI844792A 1983-12-06 1984-12-05 Foerfarande foer framstaelning av terapeutiskt anvaendbara n-2,3-butadienyl-1,4-butandiaminderivat. FI83766C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55864283A 1983-12-06 1983-12-06
US55864283 1983-12-06

Publications (4)

Publication Number Publication Date
FI844792A0 FI844792A0 (fi) 1984-12-05
FI844792L FI844792L (fi) 1985-06-07
FI83766B FI83766B (fi) 1991-05-15
FI83766C true FI83766C (fi) 1991-08-26

Family

ID=24230353

Family Applications (1)

Application Number Title Priority Date Filing Date
FI844792A FI83766C (fi) 1983-12-06 1984-12-05 Foerfarande foer framstaelning av terapeutiskt anvaendbara n-2,3-butadienyl-1,4-butandiaminderivat.

Country Status (19)

Country Link
EP (1) EP0144951B1 (enExample)
JP (1) JPS60139650A (enExample)
KR (1) KR900003528B1 (enExample)
AT (1) ATE25965T1 (enExample)
AU (1) AU574118B2 (enExample)
CA (1) CA1222527A (enExample)
DE (1) DE3462686D1 (enExample)
DK (1) DK164849C (enExample)
ES (1) ES8600201A1 (enExample)
FI (1) FI83766C (enExample)
GR (1) GR81150B (enExample)
HU (1) HU194801B (enExample)
IE (1) IE57643B1 (enExample)
IL (1) IL73797A (enExample)
NO (1) NO159081C (enExample)
NZ (1) NZ210421A (enExample)
PH (1) PH24132A (enExample)
PT (1) PT79622A (enExample)
ZA (1) ZA849412B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935449A (en) * 1988-08-04 1990-06-19 Merrell Dow Pharmaceuticals Inc. N-2,3-butadienyl tri- and tetraaminoalkane derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3712896A (en) * 1969-04-01 1973-01-23 Richardson Merrell Inc Allene polyamines

Also Published As

Publication number Publication date
EP0144951A2 (en) 1985-06-19
JPH0463058B2 (enExample) 1992-10-08
DK164849C (da) 1993-01-11
ZA849412B (en) 1985-07-31
NO844857L (no) 1985-06-07
FI844792A0 (fi) 1984-12-05
ES538308A0 (es) 1985-09-16
JPS60139650A (ja) 1985-07-24
IE57643B1 (en) 1993-02-10
HU194801B (en) 1988-03-28
EP0144951B1 (en) 1987-03-18
FI83766B (fi) 1991-05-15
PH24132A (en) 1990-03-05
KR850004575A (ko) 1985-07-25
ATE25965T1 (de) 1987-04-15
NO159081B (no) 1988-08-22
DK580484D0 (da) 1984-12-05
IL73797A0 (en) 1985-03-31
NO159081C (no) 1988-11-30
KR900003528B1 (ko) 1990-05-21
CA1222527A (en) 1987-06-02
EP0144951A3 (en) 1985-07-10
FI844792L (fi) 1985-06-07
DK164849B (da) 1992-08-31
AU574118B2 (en) 1988-06-30
GR81150B (en) 1985-04-03
IE843099L (en) 1985-06-06
NZ210421A (en) 1988-09-29
DK580484A (da) 1985-06-07
HUT37384A (en) 1985-12-28
ES8600201A1 (es) 1985-09-16
IL73797A (en) 1988-09-30
AU3631984A (en) 1985-06-13
DE3462686D1 (de) 1987-04-23
PT79622A (en) 1985-01-01

Similar Documents

Publication Publication Date Title
CZ29996A3 (en) Amidine derivatives with activities of nitrogen oxide sythetase
US4551550A (en) N-2,3-Butadienyl-1,4-butanediamine derivatives
DE69116576T2 (de) Aromatische sulfonamidderivate, ihre verwendung als enzyminhibitoren und diese verbindungen enthaltende pharmazeutische zusammensetzungen
NO128569B (enExample)
HU199413B (en) Process for producing 3-pyrrolidinols
FI83766B (fi) Foerfarande foer framstaelning av terapeutiskt anvaendbara n-2,3-butadienyl-1,4-butandiaminderivat.
CZ320095A3 (en) Process for preparing aminoalkyl guanidines
US5451608A (en) 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovasular system, processes for their preparation and pharmaceutical compositions containing them
US4851447A (en) N-2,3-butadienyl-1,4-butanediamine derivatives
CA2024283A1 (en) 3,4,5,6-tetrahydro-2h 1,7,4-benzodioxazonines as cardiovascular agents
Wang Synthesis and properties of N-acetimidoyl derivatives of glycine and sarcosine
Iwata et al. Design and synthesis of macromonocyclic polyamines composed of natural methylene arrays.
AU733001B2 (en) 5-hydroxymethyl-2-aminotetralins as cardiovascular agents
Pak et al. Regioselective Deprotection and Acylation of Penta‐N‐Protected Thermopentamine
US4292305A (en) Antiallergic imidodisulfamides
US6201120B1 (en) Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines
Detert et al. 2-Alkyl-substituted histamines and hydroxyethylimidazoles with G-protein-stimulatory activity
KR900004397B1 (ko) D-아미노산 옥시다제 기질의 제조방법
EP0781268B1 (en) Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
US5869734A (en) Preparation of optically active (S)-(-) and (R)-(+)-deoxyspergualin and novel intermediates thereof
Liu et al. Synthesis of 1, 4‐benzodiazepine‐1‐carbothioamides, bicyclic analogues of the TIBO‐type anti‐HIV agents
Mukaiyama et al. A novel method for the preparation of primary amines by the use of N-benzylhydroxylamine and 2-fluoropyridinium salt.
Zareef et al. A New Method of Reducing 2-Mercapto-Substituted 1, 3, 4-Oxadizoles: Synthesis of Acylhydrazine Derivatives
Krapcho et al. Synthesis of 1, 4-dinitroanthracene-9, 10-dione. Stepwise substitution of the nitro groups by diamines leading to 1-[(aminoalkyl) amino]-4-nitroanthracene-9, 10-diones and unsymmetrical 1, 4-bis [(aminoalkyl) amino] anthracene-9, 10-diones
FI86634C (fi) Foerfarande foer framstaellning av farmakologiskt aktiva 2-hydroxipyrid-6-ylsubstituerade amidiner.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.